Search in:

Advanced search

International Journal of Nanomedicine Volume 11, 2016 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

Xun Jin1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy

Bingwen Zou2 Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu

Li Luo1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy

Chuanhong Zhong3 Department of Neurosurgery, The Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan Province, People’s Republic of China

Peilan Zhang1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy

Hao Cheng1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy

Yanfang Guo1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy

Maling Gou1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for BiotherapyCorrespondence[email protected]

show all

Pages 4545-4552 | Published online: 08 Sep 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
PubMed Web of Science ®Google Scholar
Vargo-GogolaTRosenJMModelling breast cancer: one size does not fit allNat Rev Cancer20077965967217721431
PubMed Web of Science ®Google Scholar
Gonzalez-AnguloAMMorales-VasquezFHortobagyiGNOverview of resistance to systemic therapy in patients with breast cancerAdv Exp Med Biol200760812217993229
PubMed Web of Science ®Google Scholar
ParhiPMohantyCSahooSKNanotechnology-based combinational drug delivery: an emerging approach for cancer therapyDrug Discov Today20121717–181044105222652342
PubMed Web of Science ®Google Scholar
Al-LazikaniBBanerjiUWorkmanPCombinatorial drug therapy for cancer in the post-genomic eraNat Biotechnol201230767969222781697
PubMed Web of Science ®Google Scholar
SachlosERisuenoRMLarondeSIdentification of drugs including a dopamine receptor antagonist that selectively target cancer stem cellsCell201214961284129722632761
PubMed Web of Science ®Google Scholar
MuJXuHYangYThioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancerOncol Rep20143152107211424604290
PubMed Web of Science ®Google Scholar
ParkMSDongSMKimBRThioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenograftsOncotarget20145134929493424952635
PubMedGoogle Scholar
TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol201365215717023278683
PubMed Web of Science ®Google Scholar
KhayatDCholletPAntoineECPhase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerJ Clin Oncol200119143367337511454884
PubMedGoogle Scholar
EspelinCWLeonardSCGerettiEWickhamTJHendriksBSDual HER2 targeting with trastuzumab and liposome-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancerCancer Res20167661517152726759238
PubMed Web of Science ®Google Scholar
AmreddyNMuralidharanRBabuATumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapyInt J Nanomedicine2015106773678826604751
PubMed Web of Science ®Google Scholar
PrahalathanCSelvakumarEVaralakshmiPLipoic acid modulates adriamycin-induced testicular toxicityReprod Toxicol2006211545916112542
PubMedGoogle Scholar
BroxtermanHJGotinkKJVerheulHMUnderstanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinibDrug Resist Updat2009124–511412619648052
PubMed Web of Science ®Google Scholar
LvSTangZLiMCo-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancerBiomaterials201435236118612924794923
PubMed Web of Science ®Google Scholar
ZhangPLiJGhazwaniMEffective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapyBiomaterials20156710411426210177
PubMed Web of Science ®Google Scholar
BourzacKNanotechnology: carrying drugsNature20124917425S58S6023320289
PubMed Web of Science ®Google Scholar
BonifacioBVSilvaPBRamosMANegriKMBauabTMChorilliMNanotechnology-based drug delivery systems and herbal medicines: a reviewInt J Nanomedicine2014911524363556
PubMed Web of Science ®Google Scholar
YanLYangYZhangWChenXAdvanced materials and nanotechnology for drug deliveryAdv Mater201426315533554024449177
PubMed Web of Science ®Google Scholar
Jabr-MilaneLSvan VlerkenLEYadavSAmijiMMMulti-functional nanocarriers to overcome tumor drug resistanceCancer Treat Rev200834759260218538481
PubMed Web of Science ®Google Scholar
MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
PubMed Web of Science ®Google Scholar
IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today20061117–1881281816935749
PubMed Web of Science ®Google Scholar
CaoNFengSSDoxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluationBiomaterials200829283856386518606445
PubMed Web of Science ®Google Scholar
GaoXWangBWeiXPreparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancerInt J Nanomedicine2013897198223493403
PubMed Web of Science ®Google Scholar
UpadhyayUMTylerBPattaYIntracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brainProc Natl Acad Sci U S A201411145160711607625349381
PubMedGoogle Scholar
GuoOLiXYangYEnhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticlesJ Biomed Nanotechnol201410222723724738331
PubMed Web of Science ®Google Scholar
JiangWKimBYRutkaJTChanWCNanoparticle-mediated cellular response is size-dependentNat Nanotechnol20083314515018654486
PubMed Web of Science ®Google Scholar
ChithraniBDChanWCElucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapesNano Lett2007761542155017465586
PubMed Web of Science ®Google Scholar
ShuaiXAiHNasongklaNKimSGaoJMicellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin deliveryJ Control Release200498341542615312997
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date